Evaluation of Tumor Angiogenesis Using Dynamic Enhanced Magnetic Resonance Imaging: Comparison of Plasma Vascular Endothelial Growth Factor, Hemodynamic, and Pharmacokinetic Parameters

References

• Adams J, Carder PJ, Downey S, Forbes AM, Maclennan K, Allgar V, et al. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res 2000; 60:2898–905.
   PubMed Web of Science ®Google Scholar
• Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters E, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from plate-lets: significance for VEGF measurements and cancer biology. Br J Cancer 1998;77:956–64.
   PubMed Web of Science ®Google Scholar
• Breoer G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation: devel-opment 1992;114:521–32.
   Google Scholar
• Buadu LD, Murakami J, Murayama S, Hashiguchi S, Sakai S, Masuda K, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images 18. with histopathologic findings and tumor angiogenesis. Radiology 1996;200:639–49.
   Google Scholar
• Eppenberger U, Kueng W, Schlaeppi JM, Roesel LJ, 19. Benz C, Mueller H, et al. Markers of tumor angiogen-esis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients J Clin Oncol 1998;16: 3129–36.20.
   Google Scholar
• Flickinger FW, Allison JD, Sherry RM, Wright JC. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. 21. Magn Reson Imag 1993;11:617–20.
   PubMed Web of Science ®Google Scholar
• Foekens JA, Peters HA, Grebenchtchikov N, Look PM, 22. Gelder M, Geurts-Moespot A, et al. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. Cancer Res 2001;61: 5407–414.23.
   Google Scholar
• Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58–61.
   PubMed Web of Science ®Google Scholar
• Gasparini G, Barbareschi M, Boracchi P, Boracchi P, Verderio P, Caffo O, et al. Tumor angiogenesis predicts 24. clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemother- apy Cancer. J Sci Am 1995;1: 131–42.25.
   Google Scholar
• Gilles R, Guinebretiere JM, Lucidarme O, Cluzel P, Janaud G, Finet JF, et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 1994;191:625-31.26.
   Google Scholar
• Gimbrone Jr. M, Leapman S, Cotran R, Folkman J. Tumor dormancy in vivo by prevention of neovascular-isation. J Exp Med 1972;136:261–76.
   Google Scholar
• Gribbesttad SI, Nilsen G, Fjosne H, Fougner R, 27. Haugen AO, Petersen BS, et al. Contrast-enhanced magnetic resonance imaging of the breast. Acta Oncol 1992;193: 833–42.28.
   Google Scholar
• Hanan S, Ahmed-Emad M, Hans O, Jose H, Jens-Uwe B, Matthias T, et al. Peripheral washout sign on contrast-enhanced MR imagines of the breast. Radi- ology 1997;205:209-13.29.
   Google Scholar
• Harms SE, Flaming DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiol- 30. ogy 1993;187:493–501.
   PubMed Web of Science ®Google Scholar
• Heywang-Koebrunner SH, Haustein J, Pohl C, Beck R, Lommatzsch B, Untch M, et al. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine. Radiology 1994; 31). 191:639–46.
   Google Scholar
• Hulka PS, Smith BL, Sgrori DC, Tan L, Edmister WB, Semple JP, et al. Benign and malignant breast lesions: differentiation with echo-planar MR imaging. Radiol- 32. ogy 1995;197:33–8.
   PubMed Web of Science ®Google Scholar
• Ikeda O, Yamashita Y, Morishita S, Kido T, Kitajima M, Okamura K, et al. Characterization of breast masses by dynamic enhanced MR imaging: a logistic analysis. Acta Radiol 1999;40: 585–92.
   Google Scholar
• Ikeda 0, Yamashita Y, Morishita S. Gd-enhanced dynamic magnetic resonance imaging of breast masses. Topics in MRI 1999;10:143–51.
   Google Scholar
• Jacques AB, Ruud KKMH, Jouke S, Gerard D, Paul WAA, Jan HM, et al. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions. JMRM 1997;7:702–15.
   Web of Science ®Google Scholar
• Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radi-ology 1989;193:681–6.
   Google Scholar
• Kelsey JL. A review of the epidemiology of human breast cancer. Epidemiol Rev 1979;1:74–109.
   PubMedGoogle Scholar
• Kirsten LW, Cynthia FM, Brian KR, Medeleine M. Invasive carcinomas and fibroadenomas of the breast: comparison of mirovessel distributions - implications for imaging modalities. Radiology 1998;208:477–83.
   PubMed Web of Science ®Google Scholar
• Koide N, Nishio A, Hiraguri M, Hanazaki K, Adachi W, Amano J. Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus. Am J Gastroenterol 2001; 96:1733–40.
   PubMed Web of Science ®Google Scholar
• Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306–9.
   Google Scholar
• Liberman L, LaTrenta L, Dershaw D, Abramson AF, Morris EA, Cohen MA, et al. Impact of core biopsy on the surgical management of impalpable breast cancer. Am J Roentgenol 1997;168:495–9.
   PubMed Web of Science ®Google Scholar
• Liberman L, LaTrenta L, VanZee KJ, Morris EA, Abramson AF, Dershaw DD. Stereotactic core biopsy of calcifications highly suggestive of malignancy. Radi-ology 1997;203:673–7.
   PubMed Web of Science ®Google Scholar
• Oral SG, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic -pathologic correlation. Radiology 1994;190:485–93.
   PubMed Web of Science ®Google Scholar
• Salven P, Perhoniemi V, Tykka H, Maenpaa H, Joensuu H. Serum VEGF levels in women with a benign breast tumor or breast cancer. Breast Cancer Res Treat 1999;53:161–6.
   PubMed Web of Science ®Google Scholar
• Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357–67.
   Google Scholar
• Toi M, Inada K, Suzuki H, Tominaga T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Br J Cancer Res Treat 1995;36:193–204.
   PubMed Web of Science ®Google Scholar
• Turkat TJ, Klein BD, PoIan RL, Richman HR. MR mammography: a technique for potentially reducing the biopsy rate for benign breast disease. J Magn Reson Imag 1994;4:563–8.
   PubMed Web of Science ®Google Scholar
• Verheul HM, Hoekman K, Luykx-de Bakker S, Eekman AC, Folman CC, Broxterman JH, et al. Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 1997;3:2187–90.
   Google Scholar